Shenzhen Mindray Bio-Medical Electronics Co, Ltd. is one of the worldwide leading suppliers of medical devices and solutions. Products include patient monitoring and life support systems, in vitro diagnostics and medical imaging systems, orthopaedic implants, etc.

Employees

18,044

Sector

Advanced Medical Equipment & Technology

Calendar

2025-04-24 - Q1 2025 Earnings Release (Projected)

More about the company

Quotes

Date	Price	Change	Volume
24-12-10	262.98 ¥	+1.20%	8,825,207
24-12-09	259.85 ¥	-1.13%	4,453,386
24-12-06	262.81 ¥	+3.06%	6,987,174
24-12-05	255.00 ¥	-1.76%	5,107,458
24-12-04	259.56 ¥	-0.44%	3,629,556

End-of-day quote Shenzhen S.E., December 09, 2024

More quotes

Income Statement and Estimates

income-statement-evolution-chart SHENZHEN-MINDRAY-BIO-MEDI

More financial data

Ratings

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

262.98CNY

Average target price

350.50CNY

Spread / Average Target

+33.28%

Consensus

Profit revisions

estimates-change-chart SHENZHEN-MINDRAY-BIO-MEDI

Estimate revisions

Quarterly revenue - Rate of surprise

quality-estimates-chart SHENZHEN-MINDRAY-BIO-MEDI

Company calendar

End-of-day quote Shenzhen S.E. Other stock markets 2024-12-10			5-day change	1st Jan Change
262.98 ^CNY	+1.20%		+0.87%	-9.50%

11-05	Mindray Partners with TeleRay to Streamline Ultrasound Delivery and Enhance Outcomes	CI
10-29	Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024	CI

Capitalization	318B 43.85B 41.74B 38.68B 34.4B 62.1B 3,721B 68.82B 482B 178B 1,528B 165B 161B 6,668B	P/E ratio 2024 *	24.3x	P/E ratio 2025 *	20.7x
Enterprise value	297B 40.91B 38.94B 36.08B 32.09B 57.93B 3,472B 64.2B 449B 166B 1,425B 154B 150B 6,221B	EV / Sales 2024 *	7.67x	EV / Sales 2025 *	6.4x
Free-Float	-	Yield 2024 *	2.53%	Yield 2025 *	2.92%

Mindray Partners with TeleRay to Streamline Ultrasound Delivery and Enhance Outcomes	11-05	CI
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024	10-29	CI
Nomura Adjusts Shenzhen Mindray Bio-Medical Electronics' Price Target to 418.21 Yuan From 425.97 Yuan, Keeps at Buy	10-16	MT
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	08-29	CI
EY, KPMG benefit most from PwC China's regulatory woes	08-14	RE
Nomura Adjusts Shenzhen Mindray Bio-Medical Electronics' Price Target to 425.97 Yuan From 422.45 Yuan, Keeps at Buy	07-19	MT
Nomura Adjusts Shenzhen Mindray Bio-Medical Electronics’ Price Target to 422.45 Yuan From 441.50 Yuan, Keeps at Buy	04-29	MT
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-26	CI
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-26	CI
Mindray Says It Is Compliant with International Trade Rules Ahead of EU Probe	04-17	MT
Nomura Adjusts Shenzhen Mindray Bio-Medical’s Price Target to 441.20 Yuan From 423.39 Yuan, Keeps at Buy	03-12	MT
Majority of Shenzhen Stock Exchange-Listed Firms Post Profit Growth in 2023	01-31	MT
Mindray Bio-Medical to Buy Controlling Stake in Medical Devices Maker For 6.7 Billion Yuan	01-30	MT

Nomura Adjusts Shenzhen Mindray Bio-Medical Electronics' Price Target to 418.21 Yuan From 425.97 Yuan, Keeps at Buy	10-16	MT
Nomura Adjusts Shenzhen Mindray Bio-Medical Electronics' Price Target to 425.97 Yuan From 422.45 Yuan, Keeps at Buy	07-19	MT
Nomura Adjusts Shenzhen Mindray Bio-Medical Electronics’ Price Target to 422.45 Yuan From 441.50 Yuan, Keeps at Buy	04-29	MT
Nomura Adjusts Shenzhen Mindray Bio-Medical’s Price Target to 441.20 Yuan From 423.39 Yuan, Keeps at Buy	03-12	MT
Nomura Adjusts Shenzhen Mindray Bio-Medical Electronics' Price Target to 423.39 Yuan From 476.95 Yuan, Keeps at Buy	23-10-20	MT

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Stock

Equities

300760

CNE100003G67

Advanced Medical Equipment & Technology

Valuation: Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Chart: Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Latest news: Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Analysts' recommendations: Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Press Releases: Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

News in other languages: Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Quotes and Performance

Course Extremes

Managers and Directors: Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

ETFs: Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Quotes

Income Statement and Estimates

Ratings

Analysts' Consensus

Quarterly revenue - Rate of surprise

Mindray Expands Its Cardiac Biomarker Portfolio with Cutting-Edge hs-cTnI and NT-proBNP Assays, Empowering Enhanced Cardiovascular Diseases Care	23-10-23	AQ
Mindray and Operation Smile Begin 10-Year Partnership to Improve Healthcare for Vulnerable Communities	23-08-08	AQ
Mindray Introduces New Wearable Patient Monitoring System, Refining Clinician’s Workflow to Track Patient Conditions	22-12-04	BU
Mindray Showcases Hematology Innovations and Academic Achievements to the World at ISLH 2022	22-09-26	AQ

Wird der CSI A50 zum besten chinesischen Index?	01-08
Wordt de CSI A50 de beste Chinese index?	01-05
Il CSI A50 diventerà il miglior indice cinese?	01-04
¿Se convertirá el CSI A50 en el mejor índice chino?	01-03
Le CSI A50 va-t-il devenir le meilleur indice chinois ?	01-03

1 day	+1.20%
1 week	+0.87%
Current month	+0.96%
1 month	-7.47%
3 months	+9.12%
6 months	-12.27%
Current year	-9.50%

Director	Title	Age	Since
Hao Wu CEO	Chief Executive Officer	52	2020-11-16
Yun Zhao DFI	Director of Finance/CFO	41	2019-11-14
Yan Mei Guo PRN	Corporate Officer/Principal	61	2021-04-26

Manager	Title	Age	Since
Hang Xu CHM	Chairman	62	1999-01-24
Xi Ting Li CHM	Chairman	73	2017-01-04
Ming He Cheng BRD	Director/Board Member	63	2017-01-04

	2024 *	2025 *
Net sales	38.7B 5.34B 5.08B 4.71B 4.19B 7.56B 453B 8.37B 58.6B 21.63B 186B 20.03B 19.6B 811B	45.39B 6.26B 5.96B 5.52B 4.91B 8.86B 531B 9.82B 68.73B 25.37B 218B 23.49B 22.99B 952B
Net income	13.11B 1.81B 1.72B 1.59B 1.42B 2.56B 153B 2.84B 19.85B 7.33B 62.96B 6.78B 6.64B 275B	15.41B 2.13B 2.02B 1.87B 1.67B 3.01B 180B 3.34B 23.34B 8.62B 74.05B 7.98B 7.81B 323B
Net Debt	-21.35B -2.94B -2.8B -2.6B -2.31B -4.17B -250B -4.62B -32.33B -11.93B -103B -11.05B -10.81B -448B	-27.7B -3.82B -3.64B -3.37B -3B -5.41B -324B -5.99B -41.95B -15.49B -133B -14.34B -14.03B -581B

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi. ($)
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+1.20%	+0.87%	-11.16%	-29.04%	43.85B
THERMO FISHER SCIENTIFIC INC.	-0.26%	+0.27%	+9.41%	-16.60%	205B
INTUITIVE SURGICAL, INC.	-0.14%	-0.67%	+73.34%	+55.99%	192B
DANAHER CORPORATION	-0.67%	-2.71%	+7.75%	-26.19%	169B
BOSTON SCIENTIFIC CORPORATION	+1.67%	-0.30%	+64.15%	+119.09%	133B
SIEMENS HEALTHINEERS AG	-0.39%	+3.52%	+1.48%	-20.33%	62.94B
EDWARDS LIFESCIENCES CORPORATION	+3.51%	+4.54%	+6.09%	-39.77%	43.29B
AGILENT TECHNOLOGIES, INC.	-1.44%	+1.90%	+11.58%	-9.17%	40.48B
GE HEALTHCARE TECHNOLOGIES INC.	+0.56%	-0.25%	+20.20%	-	37.63B
RESMED, INC.	+0.19%	-0.68%	+50.56%	-6.18%	35.99B
Average	+0.29%	+0.80%	+23.34%	+3.09%	96.3B
Weighted average by Cap.	+0.03%	+0.05%	+29.84%	+14.98%